Namida Lab
Tear-based diagnostics startup
About
Founded in 2019 in Fayetteville, Arkansas, Namida Lab is a biotech startup developing non-invasive diagnostic tools based on tear fluid analysis. The company's technology uses tears as a biomarker source, enabling painless sample collection compared to traditional blood draws. Namida Lab's platform analyzes protein and molecular compositions in tears to detect biomarkers associated with various health conditions, including neurological disorders, dry eye disease, and potentially early-stage cancers. Spun out of research at the University of Arkansas.
Products
-
Auria Breast Cancer Screening
— At-home biological test for early breast cancer screening, empowering women to monitor their breast health confidently.
Customer sectors: consumers, women's health, preventive care
-
Melody Breast Cancer Diagnostic
— Clinical tear-based breast cancer diagnostic test for providers, requiring no specialized equipment or personnel.
Customer sectors: healthcare providers, diagnostic clinics, breast centers
Market research & competitive positioning
Source-backed TAM / SAM / SOM sizing, displacement analysis, and an interactive peer positioning map for Namida Lab — available to members.
